UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 29.066
NA - Nord America 18.906
EU - Europa 6.550
SA - Sud America 1.550
OC - Oceania 208
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 18
Totale 56.410
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 23.086
US - Stati Uniti d'America 18.614
SG - Singapore 2.092
CN - Cina 1.894
IT - Italia 1.439
UA - Ucraina 1.420
BR - Brasile 1.313
RU - Federazione Russa 915
DE - Germania 774
VN - Vietnam 736
IE - Irlanda 633
KR - Corea 450
TR - Turchia 397
SE - Svezia 339
FI - Finlandia 314
GB - Regno Unito 217
CA - Canada 175
EE - Estonia 146
IN - India 115
NZ - Nuova Zelanda 104
AU - Australia 98
AR - Argentina 81
MX - Messico 61
NL - Olanda 56
AT - Austria 53
FR - Francia 51
BD - Bangladesh 49
EC - Ecuador 48
PL - Polonia 39
ID - Indonesia 33
IQ - Iraq 33
JP - Giappone 32
ES - Italia 31
CZ - Repubblica Ceca 30
CO - Colombia 24
ZA - Sudafrica 24
PY - Paraguay 22
MA - Marocco 21
PK - Pakistan 20
UZ - Uzbekistan 20
VE - Venezuela 19
EU - Europa 16
IL - Israele 16
CL - Cile 15
AE - Emirati Arabi Uniti 13
DO - Repubblica Dominicana 12
BE - Belgio 11
PE - Perù 11
EG - Egitto 10
UY - Uruguay 10
KE - Kenya 9
JM - Giamaica 8
SA - Arabia Saudita 8
BG - Bulgaria 7
ET - Etiopia 7
IR - Iran 7
LT - Lituania 7
NP - Nepal 7
TN - Tunisia 7
AL - Albania 6
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
BW - Botswana 4
LU - Lussemburgo 4
ME - Montenegro 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PR - Porto Rico 4
RS - Serbia 4
SV - El Salvador 4
TW - Taiwan 4
BH - Bahrain 3
CI - Costa d'Avorio 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
TJ - Tagikistan 3
AO - Angola 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
Totale 56.353
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.067
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Dallas 1.115
Singapore 782
Houston 729
Woodbridge 616
Dublin 594
Ashburn 513
Dong Ket 459
Nanjing 399
Andover 368
Izmir 364
Beijing 329
Moscow 314
Boardman 297
Pellezzano 264
Düsseldorf 216
Mestre 203
Naples 149
Tallinn 146
Norwalk 143
Shenyang 134
Los Angeles 133
Fairfield 131
Salerno 122
Hebei 121
Munich 121
São Paulo 113
Changsha 110
Ho Chi Minh City 108
Nanchang 108
Dearborn 107
Jiaxing 85
The Dalles 67
Rome 64
Redwood City 60
New York 57
Tianjin 56
Nuremberg 54
Hanoi 53
San Diego 49
Pune 48
Rio de Janeiro 46
Auckland 43
Brooklyn 42
Columbus 42
Sydney 42
Milan 38
San Francisco 37
Santa Clara 37
Seoul 37
Council Bluffs 35
Turku 35
West Jordan 35
Belo Horizonte 33
Washington 33
Montreal 32
Amsterdam 31
Cambridge 31
Seattle 30
Brasília 29
Jinan 29
Stockholm 29
Casoria 28
Warsaw 28
Ottawa 27
Boston 24
London 24
Lappeenranta 23
Atlanta 22
Curitiba 22
Tokyo 22
Fort Worth 21
Guangzhou 21
Chicago 20
Campinas 19
Porto Alegre 19
Springfield 19
Guayaquil 18
Tashkent 18
Venezia 18
Vienna 18
Chennai 17
Phoenix 17
Shanghai 17
Baghdad 16
Melbourne 16
Quito 16
Brno 15
Guarulhos 15
Lecce 14
Toronto 14
Fortaleza 13
Hangzhou 13
Salvador 13
Ankara 12
Totale 45.637
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.156
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 959
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 921
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 909
Trial of Deferiprone in Parkinson's Disease 653
Sex Differences in Parkinson’s Disease: From Bench to Bedside 621
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 579
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 572
Cognitive impairment in nondemented Parkinson's disease. 560
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 537
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 529
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 527
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Gender differences in microRNA expression in levodopa-naive PD patients 510
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 501
A simulation tool to plan daily nurse requirements 496
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 476
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 473
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 453
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 429
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 429
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 426
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 425
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 410
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 410
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 408
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 389
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 374
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 360
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 357
Neurotransmission in Parkinson's disease: beyond dopamine. 352
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 330
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 328
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 308
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 303
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 301
Bilateral facial palsy after COVID-19 vaccination 299
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 289
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 285
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 279
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 276
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 275
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 274
A novel phenotype in an Italian family with a rare progranulin mutation 263
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 257
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 255
Trial of Cinpanemab in Early Parkinson's Disease 246
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 246
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 245
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 234
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 232
Classifying Different Stages of Parkinson’s Disease Through Random Forests 232
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 227
Metabolomics in Parkinson's disease 217
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 201
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 197
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 194
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 190
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 184
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 178
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 171
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 171
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 171
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 168
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 164
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 163
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 152
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 151
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 146
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 144
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 139
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 138
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 138
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 138
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 136
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 135
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 134
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 131
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 127
Increased bilirubin levels in de novo Parkinson's disease 123
The natural history of multiple system atrophy: A prospective European cohort study 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
Affective theory of mind in patients with Parkinson's disease: comment 122
Normative data for the Montreal Cognitive Assessment in an Italian population sample 121
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 120
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 119
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 119
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 119
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 117
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 117
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 116
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 116
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 114
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 113
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 113
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Totale 29.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 176.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.103 0 0 0 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202626.443 4.870 11.165 9.973 435 0 0 0 0 0 0 0 0
Totale 57.478